STTK Insider Trading

Insider Ownership Percentage: 10.50%
Insider Buying (Last 12 Months): $272,546.75
Insider Selling (Last 12 Months): $0.00

Shattuck Labs Insider Trading History Chart

This chart shows the insider buying and selling history at Shattuck Labs by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Shattuck Labs Share Price & Price History

Current Price: $0.95
Price Change: Price Decrease of -0.0021 (-0.22%)
As of 04/1/2025 04:02 PM ET

This chart shows the closing price history over time for STTK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.95Closing price on 03/31/25:

Shattuck Labs Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Shattuck Labs (NASDAQ:STTK)

58.74% of Shattuck Labs stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at STTK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$4.45Mbought$640ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Shattuck Labs logo
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Read More on Shattuck Labs

Today's Range

Now: $0.95
Low: $0.89
High: $1.00

50 Day Range

MA: $1.24
Low: $0.95
High: $1.91

52 Week Range

Now: $0.95
Low: $0.89
High: $11.76

Volume

97,876 shs

Average Volume

376,116 shs

Market Capitalization

$45.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Shattuck Labs?

Shattuck Labs' top insider investors include:
  1. Redmile Group, Llc (Director)
  2. Tyler Brous (Director)
  3. Andrew R Neill (CFO)
  4. Stephen Stout (Insider)
  5. Taylor Schreiber (CEO)
Learn More about top insider investors at Shattuck Labs.

Who are the major institutional investors of Shattuck Labs?

Shattuck Labs' top institutional investors include:
  1. Prosight Management LP — 13.91%
  2. Redmile Group LLC — 11.60%
  3. Adage Capital Partners GP L.L.C. — 9.79%
  4. 683 Capital Management LLC — 2.20%
  5. Takeda Pharmaceutical Co. Ltd. — 1.08%
  6. Northern Trust Corp — 0.74%
Learn More about top institutional investors of Shattuck Labs stock.

Which institutional investors are selling Shattuck Labs stock?

During the last quarter, STTK stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Ritholtz Wealth Management
  3. Dimensional Fund Advisors LP
  4. Redmile Group LLC
  5. Two Sigma Investments LP
  6. Two Sigma Advisers LP
  7. Bridgeway Capital Management LLC
  8. Citadel Advisors LLC

Which institutional investors are buying Shattuck Labs stock?

In the last quarter, STTK stock was acquired by institutional investors including:
  1. Adage Capital Partners GP L.L.C.
  2. 683 Capital Management LLC
  3. Prosight Management LP
  4. Takeda Pharmaceutical Co. Ltd.
  5. Bank of America Corp DE
  6. JPMorgan Chase & Co.
  7. Deutsche Bank AG
  8. Millennium Management LLC
During the last year, these company insiders have bought Shattuck Labs stock:
  1. Redmile Group, Llc (Director)
  2. Tyler Brous (Director)
  3. Andrew R Neill (CFO)
Learn More investors buying Shattuck Labs stock.